miR-200c increases the sensitivity of breast cancer cells to Doxorubicin through downregulating MDR1 gene
Sahar Safaei, Mohammad Amini, Shiva Najjary, Ahad Mokhtarzadeh, Nadia Bolandi, Hossein Saeedi, Nazila Alizadeh, Darya Javadrashid, Behzad Baradaran
Topics & Concepts
TransfectionDoxorubicinmicroRNAViability assayApoptosisBreast cancerCancer researchCancerMTT assayMCF-7Gene expressionSuppressorCancer cellBiologyTumor suppressor geneGeneMedicineChemotherapyInternal medicineCarcinogenesisGeneticsHuman breastMicroRNA in disease regulationCircular RNAs in diseasesCytokine Signaling Pathways and Interactions